In Vivo Molecular Imaging 2012

Molecular imaging remains an important tool in drug discovery and development. This noninvasive technology delivers significant time and cost reduction when used systematically and skillfully. Cambridge Healthtech Institute’s Third Annual Molecular Imaging in Drug Discovery and Development is designed to bring together leading molecular imaging experts from industry and academia, as well as scientists who use their services to accelerate the research. It will present solutions and case studies for an array of problems as well as feature a broad spectrum of technological advances in pre-clinical molecular imaging. The main emphasis will be made on molecular imaging applications/use of imaging biomarkers on various stages of drug discovery and development.